Effects of allopurinol on gouty and non-gouty uric acid nephropathy.
Explore the source record for details and available documents.
Allopurinol↗
SEARCH · PubMed Health
Results for “SULFINPYRAZONE”
Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Long-term use of allopurinol in the treatment of gout.
Explore the source record for details and available documents.
Adolescent↗
Pharmacology of uricosuric drugs.
Explore the source record for details and available documents.
Absorption↗
Letter: Medical management of transient ischaemic attacks.
Explore the source record for details and available documents.
Anti-Inflammatory Agents↗
Sulphinpyrazone, cardiac infarction, and the prevention of death: a successful trial or another tribulation?
Explore the source record for details and available documents.
Humans↗
Committee on the Review of Medicines. Recommendations on phenylbutazone, oxyphenbutazone, feprazone, allopurinol, colchicine, probenecid, and sulphinpyrazone.
Explore the source record for details and available documents.
Adult↗
Sulphinpyrazone after myocardial infarction.
Explore the source record for details and available documents.
Arrhythmias, Cardiac↗
Hazards of sulphinpyrazone.
Explore the source record for details and available documents.
Drug Synergism↗
Acute myelomonocytic leukaemia and multiple myeloma after sulphinpyrazone and colchicine treatment of gout.
Explore the source record for details and available documents.
Aged↗
Sulphinpyrazone in acute stuttering hemiparesis.
Explore the source record for details and available documents.
Acute Disease↗
Sulphinpyrazone and prevention of death after myocardial infarction.
Explore the source record for details and available documents.
Humans↗
Hazards of sulphinpyrazone.
Explore the source record for details and available documents.
Anticoagulants↗
Sulphinpyrazone and warfarin after myocardial infarction.
Explore the source record for details and available documents.
Drug Therapy, Combination↗
Sulphinpyrazone and warfarin after myocardial infarction.
Explore the source record for details and available documents.
Drug Combinations↗
Secondary prevention of myocardial infarction--the present state of the ART.
Explore the source record for details and available documents.
Anticoagulants↗
Studies of myocardial infarction.
Explore the source record for details and available documents.
Aspirin↗
Sulphinpyrazone in acute myocardial infarction: studies on cardiac rhythm and renal function.
Ninety-eight patients with acute myocardial infarction were randomly allocated to receive sulphinpyrazone 200 mg four times daily or placebo on admission to a coronary care unit. Twenty-four-hour electrocardiogram tape recordings showed no significant reduction in serious arrhythmias in the sulphinpyrazone-treated group. In addition to the expected all in serum urate concentration, patients taking sulphinpyrazone showed a persistent increase in their serum urea and creatinine concentrations when compared with those in the placebo groups (p < 0.05 and p < 0.01 respectively). These differences could not be accounted for by differences in the extent and severity of the infarction between the two groups. These results suggest that sulphinpyrazone has no discernible antiarrhythmic effect in acute myocardial infarction.
Arrhythmias, Cardiac↗